Cian McCarthy, MD
Enriched profileAssistant Professor of Medicine, Harvard Medical School · Massachusetts General Hospital
Cian McCarthy is Assistant Professor of Medicine, Harvard Medical School at Massachusetts General Hospital. OpenAlex indexes 114 publications with 4,866 citations (h-index 26); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Cian McCarthy, MD, is Assistant Professor of Medicine, Harvard Medical School at Massachusetts General Hospital (Mass General Brigham Heart and Vascular Institute). The public record shows 114 publications with 4,866 citations (h-index 26), centered on Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, Coronary Interventions and Diagnostics. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 7 companies, 1 NIH-funded awards (2023–2025).
- Most recent indexed publication: 2024 · European heart journal
- Top research focus: Acute Myocardial Infarction Research
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 53.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational Calls
Sponsor: Massachusetts General Hospital
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year202510 payments$11,765openpaymentsdata.cms.gov ↗
- ROCHE DIAGNOSTICS INTERNATIONAL LTDProgram year20252 payments
- Azurity Pharmaceuticals, Inc.Program year20258 payments
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
59.1%Beta blocker34.5%Metoprolol Succinate100%Part D≥12 patientsCalcium channel blocker12.7%Amlodipine Besylate100%Part D<11 patientsBlood & clotting
40.9%Factor Xa inhibitor26.4%Eliquis100%Part D<11 patientsP2Y12 inhibitor14.5%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2023–2025 per NIH RePORTER. The latest:
- Improving the Health Status of Individuals with Type 2 Myocardial Infarction
Massachusetts General Hospital
FY2025$196,384K23HL167659 - Improving the Health Status of Individuals with Type 2 Myocardial Infarction
Massachusetts General Hospital
FY2024$196,384K23HL167659 - Improving the Health Status of Individuals with Type 2 Myocardial Infarction
Massachusetts General Hospital
FY2023$196,384K23HL167659
Congress activity
Updated 27 Aug 2026
2 congress contributions (2018–2019) across ADA per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The 'ten commandments' for the 2024 European Society of Cardiology guidelines on elevated blood pressure and hypertension.
European heart journal
Article2024 - 2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
European heart journal
Guideline2024 - In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine.
Journal of interventional cardiology
Article2018
Most-cited works
by citation count (OpenAlex)- 012024 ESC Guidelines for the management of elevated blood pressure and hypertensionArticle2,197 citations2024
- 02Cardiovascular Disease Projections in the United States Based on the 2020 Census EstimatesArticle303 citations2022
- 03
- 04Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin AssaysArticle135 citations2019
- 05Effect of Neprilysin Inhibition on Various Natriuretic Peptide AssaysArticle125 citations2019
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- X / Twitter
x.com/CianPMcCarthy
Mentions by others
where others cite or feature them- Other
advances.massgeneral.org/contributors/contributor.aspx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →advances.massgeneral.org ↗ - Other
esc365.escardio.org/person/518603
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →esc365.escardio.org ↗ - X / Twitter
Active on X (Twitter) as @CianPMcCarthy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- MB BCh BAO
University College Cork School of Medicine (2015, first-class honors) -- equivalent physician degree corroborating NPI registry MD credential
2015verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Board Certified
Internal Medicine (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Board Certified
Cardiovascular Disease (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →massgeneral.org ↗
Editorial & leadership roles
journal and society appointments- Task Force Co-ordinator
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗ - Associate Editor
Epidemiology, Prevention, and Health Care Policies, European Heart Journal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
Awards & honors
honors on the public recordSecondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital